Natera Inc Stock
€278.00
Your prediction
Natera Inc Stock
Pros and Cons of Natera Inc in the next few years
Pros
Cons
Performance of Natera Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natera Inc | 1.280% | 15.482% | 16.068% | 100.365% | 39.340% | 433.010% | 180.102% |
| Orthofix Medical Inc. | 1.160% | -16.019% | -11.282% | -20.642% | -32.946% | -51.404% | -73.788% |
| Lantheus Holdings Inc | 0.230% | -0.455% | -5.508% | 89.599% | 52.972% | 38.889% | - |
| IRadimed Corp | -1.300% | -6.173% | -11.628% | 25.620% | -8.434% | - | - |
News
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs
Solomon Moshkevich, president of clinical diagnostics at Natera, Inc. (NASDAQ:NTRA), sold 3,410 shares of common stock on August 3, according to an SEC Form 4 filing.
Transaction value based on SEC
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests
Executive Chairman Matthew Rabinowitz reported a sale of 2,000 shares of Natera, Inc. (NASDAQ:NTRA) in a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
Matthew Rabinowitz, the executive chairman of Natera, Inc. (NASDAQ:NTRA), sold 731 shares of common stock at $267.99 per share on August 3, according to an SEC Form 4 filing.
Transaction value based


